Frequent Monitoring of A1C During Pregnancy As a Treatment Tool to Guide Therapy

Overview

Journal Diabetes Care

Specialty Endocrinology

Date 2010 Oct 6

PMID 20921215

Citations 21

Authors

Lois Jovanovic

Hatice Savas

Manish Mehta

Angelina Trujillo

David J Pettitt

Affiliations

Soon will be listed here.

Abstract

Objective: No guidelines for A1C measurement exist for women with gestational diabetes mellitus (GDM). The aim of this study was to document the rate of A1C decline in women with GDM.

Research Design And Methods: Women with GDM in the Santa Barbara County Endocrine Clinic are managed with a carbohydrate-restricted diet and self-monitored blood glucose before and 1-h postprandial. Insulin is started if the preprandial glucose concentration is ≥90 mg/dl and/or a 1-h postprandial glucose concentration is ≥120 mg/dl. Capillary A1C was tested weekly using the DCA2000+ analyzer.

Results: Twenty-four women with GDM (aged 29.0 ± 7.3 years) with initial A1C ≥7.0% were recruited. Baseline A1C was 8.8 ± 1.8%. Mean A1C decline was 0.47% per week (range 0.10-1.15%); the maximum was 4.3% in 4 weeks.

Conclusions: This study documents rapid decline in A1C during pregnancy and the utility of weekly A1C to guide therapy.

Citing Articles

Unveiling Gestational Diabetes: An Overview of Pathophysiology and Management.

Mittal R, Prasad K, Lemos J, Arevalo G, Hirani K Int J Mol Sci. 2025; 26(5).

PMID: 40076938 PMC: 11900321. DOI: 10.3390/ijms26052320.

2023 Clinical Practice Guidelines for Diabetes Management in Korea: Full Version Recommendation of the Korean Diabetes Association.

Moon J, Kang S, Choi J, Lee K, Moon J, Chon S Diabetes Metab J. 2024; 48(4):546-708.

PMID: 39091005 PMC: 11307112. DOI: 10.4093/dmj.2024.0249.

The relationship between SGLT2 and systemic blood pressure regulation.

Ahwin P, Martinez D Hypertens Res. 2024; 47(8):2094-2103.

PMID: 38783146 PMC: 11298408. DOI: 10.1038/s41440-024-01723-6.

6. Glycemic Goals and Hypoglycemia: Standards of Care in Diabetes-2024.

Diabetes Care. 2023; 47(Suppl 1):S111-S125.

PMID: 38078586 PMC: 10725808. DOI: 10.2337/dc24-S006.

6. Glycemic Targets: Standards of Care in Diabetes-2023.

ElSayed N, Aleppo G, Aroda V, Bannuru R, Brown F, Bruemmer D Diabetes Care. 2022; 46(Suppl 1):S97-S110.

PMID: 36507646 PMC: 9810469. DOI: 10.2337/dc23-S006.

References

Agarwal M, Dhatt G, Punnose J, Koster G . Gestational diabetes: a reappraisal of HBA1c as a screening test. Acta Obstet Gynecol Scand. 2005; 84(12):1159-63. DOI: 10.1111/j.0001-6349.2005.00650.x. View

Balaji V, Madhuri B, Ashalatha S, Sheela S, Suresh S, Seshiah V . A1C in gestational diabetes mellitus in Asian Indian women. Diabetes Care. 2007; 30(7):1865-7. DOI: 10.2337/dc06-2329. View

Jovanovic-Peterson L, Bevier W, Peterson C . The Santa Barbara County Health Care Services program: birth weight change concomitant with screening for and treatment of glucose-intolerance of pregnancy: a potential cost-effective intervention?. Am J Perinatol. 1997; 14(4):221-8. DOI: 10.1055/s-2007-994131. View

Tamborlane W, Kollman C, Steffes M, Ruedy K, Dongyuan X, Beck R . Comparison of fingerstick hemoglobin A1c levels assayed by DCA 2000 with the DCCT/EDIC central laboratory assay: results of a Diabetes Research in Children Network (DirecNet) Study. Pediatr Diabetes. 2005; 6(1):13-6. DOI: 10.1111/j.1399-543X.2005.00088.x. View

Bevier W, Fischer R, Jovanovic L . Treatment of women with an abnormal glucose challenge test (but a normal oral glucose tolerance test) decreases the prevalence of macrosomia. Am J Perinatol. 1999; 16(6):269-75. DOI: 10.1055/s-2007-993871. View

Lurie S, Mamet Y . Red blood cell survival and kinetics during pregnancy. Eur J Obstet Gynecol Reprod Biol. 2000; 93(2):185-92. DOI: 10.1016/s0301-2115(00)00290-6. View

Karcaaltincaba D, Yalvac S, Kandemir O, Altun S . Glycosylated hemoglobin level in the second trimester predicts birth weight and amniotic fluid volume in non-diabetic pregnancies with abnormal screening test. J Matern Fetal Neonatal Med. 2010; 23(10):1193-9. DOI: 10.3109/14767050903511586. View

Mills J, Simpson J, DRISCOLL S, Jovanovic-Peterson L, Van Allen M, AARONS J . Incidence of spontaneous abortion among normal women and insulin-dependent diabetic women whose pregnancies were identified within 21 days of conception. N Engl J Med. 1988; 319(25):1617-23. DOI: 10.1056/NEJM198812223192501. View

Bode B, Irvin B, Pierce J, Allen M, Clark A . Advances in hemoglobin A1c point of care technology. J Diabetes Sci Technol. 2009; 1(3):405-11. PMC: 2769587. DOI: 10.1177/193229680700100314. View

10.

Jovanovic L, Peterson C . The clinical utility of glycosylated hemoglobin. Am J Med. 1981; 70(2):331-8. DOI: 10.1016/0002-9343(81)90770-1. View

11.

Mills J, Knopp R, Simpson J, Jovanovic-Peterson L, Metzger B, Holmes L . Lack of relation of increased malformation rates in infants of diabetic mothers to glycemic control during organogenesis. N Engl J Med. 1988; 318(11):671-6. DOI: 10.1056/NEJM198803173181104. View

12.

Schrader H, Jovanovic-Peterson L, Bevier W, Peterson C . Fasting plasma glucose and glycosylated plasma protein at 24 to 28 weeks of gestation predict macrosomia in the general obstetric population. Am J Perinatol. 1995; 12(4):247-51. DOI: 10.1055/s-2007-994465. View

13.

Sapienza A, Francisco R, Trindade T, Zugaib M . Factors predicting the need for insulin therapy in patients with gestational diabetes mellitus. Diabetes Res Clin Pract. 2010; 88(1):81-6. DOI: 10.1016/j.diabres.2009.12.023. View